Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

NCT01390571 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cancer Research UK